Acusera Smart Liquid Cardiac
Home -
The Acusera Smart Liquid Cardiac Control is designed to cover a range of cardiac markers at clinical decision levels, eliminating the need for additional low-level controls at extra expenses. It is intended for use with in vitro diagnostic assays for the quantitative determination of 7 cardiac markers. This control also has an impressive 14 day open vial stability for Troponin I, and 30 days for other analytes. It is designed for use in the routine monitoring of both accuracy and precision.
Features & Benefits
- Liquid frozen requiring minimal preparation
- Human serum based providing a matrix similar to the patient sample
- Open vial stability of 30 days at 2-8ºC for most analytes (excluding Troponin I)
- Consolidates 7 key cardiac markers
- Cut off levels for Troponin I in line with internationally recommended levels
| Description | Size | Analytes | Cat No |
|---|---|---|---|
| Smartscan Liquid Cardiac Controls Level 1 (Siemens Atellica) | 5 x 3 ml | 7 | CQ10616 |
| Smartscan Liquid Cardiac Controls Level 2 (Siemens Atellica) | 5 x 3 ml | 7 | CQ10617 |
| Smartscan Liquid Cardiac Controls Level 3 (Siemens Atellica) | 5 x 3 ml | 7 | CQ10618 |
| Description | Size | Analytes | Cat No |
|---|---|---|---|
| Smartload Liquid Cardiac Controls Level 1 | 5 x 3 ml | 7 | CQ10534 |
| Smartload Liquid Cardiac Controls Level 2 | 5 x 3 ml | 7 | CQ10535 |
| Smartload Liquid Cardiac Controls Level 3 | 5 x 3 ml | 7 | CQ10536 |
Analytes
- CK-MB
- Homocysteine
- hsCRP
- Myoglobin
- Troponin I
- Digoxin
- NT-proBNP